Synergy CHC Corp. (SNYR) Fair Value 2026

SNYR · Medical Distribution ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.6 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-08-28, Synergy CHC Corp. (SNYR) trades at $0.10. QOC: 4.6/10. Value Trap Risk: 53/100 (WARN). 1/13 models active.

Key Facts

Ticker
SNYR
Price
$0.10
Quality Score
4.6/10
Value Trap Risk
53/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give SNYR?

1 Intrinsic Value Models vs. Current Price ($0.10)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $0.09 -9.5%

All Models Active

All 1 models are displayed above.

What Is Synergy CHC Corp. (SNYR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Synergy CHC Corp.'s intrinsic value is estimated at $0.09. Trading at its current price of $0.10, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -9.5%.

What Do the Models Say About SNYR?

1 of 13 models are currently active for SNYR. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does SNYR Rank in Medical Distribution?

Among 13 Medical Distribution stocks, SNYR ranks #9 by Quality of Company score. CirclFi's QOC score of 4.6/10 evaluates 32 fundamental signals. A score of 4.6 reflects mixed fundamentals.

Synergy CHC Corp. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SNYR a Value Trap?

CirclFi's Value Trap algorithm assigns SNYR a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Synergy CHC Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Synergy CHC Corp. earns a quality score of 4.6/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SNYR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SNYR's 1 active models, average confidence is 36%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Synergy CHC Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Distribution Stocks Should You Also Analyze?

9 related Medical Distribution stocks with 13-model coverage

VNOVVNOVQOC 5.6COSMCosmos Health Inc.QOC 4.5FOCLEDAP TMS S.A.QOC 5.8MEDSDataMEDS AI, Inc.QOC 4.3ACHAccendra Health, Inc.QOC 5.8HKPDCellyan Biotechnology Co., LtdQOC 2.5CORCencora, Inc.QOC 8.3YI111, Inc.QOC 6.8MCKMcKesson CorporationQOC 8.7

Read investment analysis: VNOV · COSM · FOCL · MEDS · ACH · HKPD · COR · YI · MCK

Which Other Stocks Have a Similar Quality Score to SNYR?

7 companies across all industries closest to SNYR’s Quality of Company score of 4.6/10.

OFSOFS Capital CorporationQOC 4.6CJMBCallan JMB Inc.QOC 4.6WETOWetour Robotics LimitedQOC 4.6UNIBUniversity Bancorp, Inc.QOC 4.6AQMSAqua Metals, Inc.QOC 4.6GIPRGeneration Income Properties, Inc.QOC 4.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: OFS · CJMB · WETO · UNIB · AQMS · GIPR · NVDA

What Else Do Investors Ask About Synergy CHC Corp.’s Valuation?

What is Synergy CHC Corp.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Synergy CHC Corp. (SNYR). The Quality of Company score is 4.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SNYR overvalued or undervalued right now?

At $0.10, 0 of 1 active models suggest SNYR may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits Synergy CHC Corp.'s business model in Medical Distribution.

What does a Quality of Company score of 4.6 mean for SNYR?

Synergy CHC Corp.'s QOC of 4.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on SNYR?

CirclFi analyzes SNYR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is SNYR a value trap in 2026?

Synergy CHC Corp.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Synergy CHC Corp. (SNYR) a Quality of Company score of 4.6/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SNYR/ · Methodology
Primary sources for this SNYR valuation
  • Financial statements: Synergy CHC Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001562733) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SNYR as of ; valuations recomputed .